CVRX vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 11, 2026

CVRX

42.6
AI Score
VS
JBIO Wins

JBIO

44.8
AI Score

Investment Advisor Scores

CVRX

43score
Recommendation
HOLD

JBIO

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CVRX JBIO Winner
Net Income -53.31M -96.13M CVRX
Operating Income -51.27M -102.36M CVRX
ROE -135.6% -21.9% JBIO
ROA -50.9% -20.4% JBIO
Total Assets 104.79M 472.11M JBIO
Cash 75.71M 107.25M JBIO
Current Ratio 7.63 14.93 JBIO
Free Cash Flow -40.75M -67.93M CVRX

Relative Price Performance (Last 90 Days)

CVRX 1M: -41.9% · 3M: -53.2% JBIO 1M: +8.8% · 3M: -9.0%

Current Technical Phase

CVRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.1%), weak momentum, RSI 35

RSI (14): 34.6 · Price: $2.84

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $21.34

Fundamentals Snapshot

Metric CVRX JBIO
Market Cap
Forward P/E -1.5 -8.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.9%
Operating Margin -0.8% 0.0%
EPS -1.97 -1.01
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.